Biolargo Stock Buy Hold or Sell Recommendation
| BLGO Stock | USD 0.31 0.02 6.06% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding BioLargo is 'Hold'. Macroaxis provides BioLargo buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BioLargo positions. The advice algorithm takes into account all of BioLargo's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting BioLargo's buy or sell advice are summarized below:
Real Value 0.26 | Hype Value 0.31 | Market Value 0.31 | Naive Value 0.32 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell BioLargo given historical horizon and risk tolerance towards BioLargo. When Macroaxis issues a 'buy' or 'sell' recommendation for BioLargo, the advice is generated through an automated system that utilizes algorithms and statistical models.
BioLargo |
Execute BioLargo Buy or Sell Advice
The BioLargo recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on BioLargo. Macroaxis does not own or have any residual interests in BioLargo or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute BioLargo's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Good | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
BioLargo Trading Alerts and Improvement Suggestions
| BioLargo is way too risky over 90 days horizon | |
| BioLargo has some characteristics of a very speculative penny stock | |
| BioLargo appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 2.53 M. Net Loss for the year was (7.08 M) with profit before overhead, payroll, taxes, and interest of 1.1 M. | |
| BioLargo currently holds about 1.23 M in cash with (3.94 M) of positive cash flow from operations. | |
| Roughly 15.0% of the company shares are held by company insiders |
BioLargo Returns Distribution Density
The distribution of BioLargo's historical returns is an attempt to chart the uncertainty of BioLargo's future price movements. The chart of the probability distribution of BioLargo daily returns describes the distribution of returns around its average expected value. We use BioLargo price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of BioLargo returns is essential to provide solid investment advice for BioLargo.
| Mean Return | 0.75 | Value At Risk | -6.06 | Potential Upside | 11.11 | Standard Deviation | 5.30 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of BioLargo historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
BioLargo Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to BioLargo or Chemicals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that BioLargo's price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a BioLargo otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.68 | |
β | Beta against NYSE Composite | 1.09 | |
σ | Overall volatility | 5.30 | |
Ir | Information ratio | 0.13 |
BioLargo Volatility Alert
BioLargo shows above-average downside volatility for the selected time horizon. BioLargo is a potential penny stock. Although BioLargo may be in fact a good instrument to invest, many penny otc stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in BioLargo. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on BioLargo instrument if you perfectly time your entry and exit. However, remember that penny otcs that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.BioLargo Fundamentals Vs Peers
Comparing BioLargo's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BioLargo's direct or indirect competition across all of the common fundamentals between BioLargo and the related equities. This way, we can detect undervalued stocks with similar characteristics as BioLargo or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of BioLargo's fundamental indicators could also be used in its relative valuation, which is a method of valuing BioLargo by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare BioLargo to competition |
| Fundamentals | BioLargo | Peer Average |
| Return On Equity | -3.63 | -0.31 |
| Return On Asset | -0.69 | -0.14 |
| Profit Margin | (1.29) % | (1.27) % |
| Operating Margin | (1.16) % | (5.51) % |
| Current Valuation | 52.87 M | 16.62 B |
| Shares Outstanding | 275.42 M | 571.82 M |
| Shares Owned By Insiders | 14.70 % | 10.09 % |
| Shares Owned By Institutions | 0.04 % | 39.21 % |
| Price To Earning | (4.54) X | 28.72 X |
| Price To Book | 10.61 X | 9.51 X |
| Price To Sales | 11.52 X | 11.42 X |
| Revenue | 2.53 M | 9.43 B |
| Gross Profit | 1.1 M | 27.38 B |
| EBITDA | (6.64 M) | 3.9 B |
| Net Income | (7.08 M) | 570.98 M |
| Cash And Equivalents | 1.23 M | 2.7 B |
| Total Debt | 367 K | 5.32 B |
| Debt To Equity | 0.72 % | 48.70 % |
| Current Ratio | 1.82 X | 2.16 X |
| Book Value Per Share | 0.02 X | 1.93 K |
| Cash Flow From Operations | (3.94 M) | 971.22 M |
| Earnings Per Share | (0.03) X | 3.12 X |
| Target Price | 0.29 | |
| Number Of Employees | 31 | 18.84 K |
| Beta | -0.0345 | -0.15 |
| Market Capitalization | 64.59 M | 19.03 B |
| Total Asset | 3.02 M | 29.47 B |
| Retained Earnings | (89.68 M) | 9.33 B |
| Working Capital | 1.04 M | 1.48 B |
| Current Asset | 1.87 M | 9.34 B |
| Current Liabilities | 831 K | 7.9 B |
| Z Score | 57.8 | 8.72 |
| Net Asset | 3.02 M |
BioLargo Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as BioLargo . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About BioLargo Buy or Sell Advice
When is the right time to buy or sell BioLargo? Buying financial instruments such as BioLargo OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having BioLargo in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Growth Funds Thematic Idea Now
Small Growth Funds
Funds or Etfs that invest in stocks of small to mid-sized companies with above-average risk and growth rate that usually reinvest their earnings back into business. The Small Growth Funds theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Growth Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out BioLargo Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the BioLargo information on this page should be used as a complementary analysis to other BioLargo's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for BioLargo OTC Stock analysis
When running BioLargo's price analysis, check to measure BioLargo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLargo is operating at the current time. Most of BioLargo's value examination focuses on studying past and present price action to predict the probability of BioLargo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLargo's price. Additionally, you may evaluate how the addition of BioLargo to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |